A61K 31/4162
Condensed with heterocyclic ring systems
Official title: condensed with heterocyclic ring systems
A61K31/4162 (Condensed with heterocyclic ring systems) appears on 307 US grants and 537 published applications in this corpus.
Search patents in A61K- Granted patents
- 307
- Published applications
- 537
- Assignees
- 265
- Inventors
- 1,382
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 1 |
| 2002 | 1 | 1 |
| 2003 | 1 | 10 |
| 2004 | 2 | 4 |
| 2005 | 0 | 7 |
| 2006 | 3 | 6 |
| 2007 | 2 | 7 |
| 2008 | 2 | 5 |
| 2009 | 0 | 14 |
| 2010 | 4 | 14 |
| 2011 | 3 | 14 |
| 2012 | 9 | 11 |
| 2013 | 13 | 18 |
| 2014 | 16 | 27 |
| 2015 | 27 | 51 |
| 2016 | 18 | 34 |
| 2017 | 24 | 31 |
| 2018 | 31 | 46 |
| 2019 | 32 | 34 |
| 2020 | 29 | 30 |
| 2021 | 21 | 36 |
| 2022 | 16 | 35 |
| 2023 | 14 | 31 |
| 2024 | 16 | 30 |
| 2025 | 11 | 16 |
| 2026 | 10 | 24 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Bacterial DNA gyrase inhibitors and methods of use thereof25 Aug 2026US 12,714,692 B2The Florida International University Board of Trustees
- Modulators of FPR1 and methods of using the same11 Aug 2026US 12,703,708 B2Biofront Therapeutics (Beijing) Co., Ltd.
- Combination therapy of GPR119 agonists and DPP-4 inhibitors30 Jun 2026US 12,667,566 B2Mankind Pharma Ltd.
- Macrocyclic compounds, compositions, and methods of using thereof9 Jun 2026US 12,649,750 B2Genzyme Corporation
- Compositions for use in the prevention and/or treatment of intellectual disability and neurodegenerative diseases in a subject with down syndrome26 May 2026US 12,636,284 B2Universita' Degli Studi Di Roma “La Sapienza”
- Heterocyclic Compound And Use Thereof In Medicine17 Sep 2026US 2026/0274800 A1Kangbaida (Sichuan) Biotechnology Co., Ltd.
- Immunomodulator3 Sep 2026US 2026/0258050 A1Hitgen Inc.
- Methods for inducing ferroptosis in cancer27 Aug 2026US 2026/0248767 A1Board of Regents, The University of Texas System
- 1-aminosulfonyl-2-carboxypyrrole derivatives as metallo-beta-lactamase inhibitors20 Aug 2026US 2026/0240811 A1INFEX Therapeutics Limited
- Nbd1 modulators and methods of using the same20 Aug 2026US 2026/0242388 A1Genzyme Corporation
Most cited
By later US patents
- Pyrazole compound and medicinal composition containing the same142US 7,429,609 B2Eisai R&D Management Co., Ltd. · 2008
- Angiogenesis inhibitors110US 7,166,293 B2Carlsbad Technology, Inc. · 2007
- Compositions and methods for treatment of eye disorders84US 8,168,655 B2Sarcode Bioscience Inc. · 2012
- Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin39US 9,802,900 B2Global Blood Therapeutics, Inc. · 2017
- Compounds and methods of treating ocular disorders33US 8,722,669 B2Case Western Reserve University · 2014